Prediction of High-Performing Spleen-Targeted Lipid Nanoparticles Using a Deep Learning Model for Robust Anticancer Immunotherapy†

Messenger RNA (mRNA) therapeutics hold significant potential across a wide range of medical applications. LNPs are the most clinically advanced mRNA delivery vehicles, but challenges such as off-target effects and...